Evidence map›Paper›PMID 26379794›Full record

ArticleJournal of neurodevelopmental disorders2015

Anxiety-like behavior in Rett syndrome: characteristics and assessment by anxiety scales.

Katherine V Barnes, Francesca R Coughlin, Heather M O'Leary, Natalie Bruck, Grace A Bazin, Emily B Beinecke, Alexandra C Walco, Nicole G Cantwell, Walter E Kaufmann

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Journal of neurodevelopmental disorders, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 52 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 4 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01777542 phase2completednot on this map

Pharmacological Treatment of Rett Syndrome by Stimulation of Synaptic Maturation With Recombinant Human IGF-1(Mecasermin [rDNA] Injection)

TypeinterventionalSponsorBoston Children's HospitalRan2013 to 2016Enrolled30ConditionsRett SyndromeArmsRecombinant Human Insulin Growth Factor 1 (rhIGF-1), Placebo
NCT03196323 completednot on this mapstarted 2017, after this paper: background citation

Development of a Behavioral Outcome Measure for Rett Syndrome (RettBe)

TypeobservationalSponsorUniversity of South FloridaRan2017 to 2020Enrolled146ConditionsRett Syndrome
3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 4 syntheses or guidelines pooled it, 95 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Protective role of mirtazapine in adult female Mecp2Journal of neurodevelopmental disorders · 2020
    Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Reciprocal regulation of the HbioRxiv : the preprint server for biology · 2025
    Article
  13. Rett Syndrome Behaviour Questionnaire: Variability of Scores and Related Factors.Journal of child and adolescent psychopharmacology · 2025
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Katherine V BarnesDepartment of Neurology, Boston Children's Hospital, Boston, MA 02115 USA ; Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115 USA.
Francesca R CoughlinDepartment of Neurology, Boston Children's Hospital, Boston, MA 02115 USA ; Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115 USA.
Heather M O'LearyDepartment of Neurology, Boston Children's Hospital, Boston, MA 02115 USA ; Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115 USA.
Natalie BruckDepartment of Neurology, Boston Children's Hospital, Boston, MA 02115 USA ; Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115 USA.
Grace A BazinDepartment of Neurology, Boston Children's Hospital, Boston, MA 02115 USA ; Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115 USA.
Emily B BeineckeDepartment of Neurology, Boston Children's Hospital, Boston, MA 02115 USA ; Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115 USA.
Alexandra C WalcoDepartment of Neurology, Boston Children's Hospital, Boston, MA 02115 USA ; Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115 USA.
Nicole G CantwellDepartment of Neurology, Boston Children's Hospital, Boston, MA 02115 USA ; Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115 USA.
Walter E KaufmannDepartment of Neurology, Boston Children's Hospital, Boston, MA 02115 USA ; Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115 USA.
Boston Children's Hospital · USHarvard University · US

Funding

HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)UL1RR025758 · NCRR · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2008 to 2011
$91.4M
SYNAPTIC MECHANISMS IN HIPPOCAMPAL EPILEPTOGENESISP30HD018655 · NICHD · CHILDREN'S HOSPITAL BOSTON · PI CHEN, CHINFEI · 1985 to 2015
$26.2M
NCRR NIH HHS UL1 RR025758NICHD NIH HHS P30 HD018655
6 · The paper itself

Abstract

backgroundRett syndrome (RTT) is a severe neurodevelopmental disorder characterized by regression of language and motor skills, cognitive impairment, and frequent seizures. Although the diagnostic criteria focus on communication, motor impairments, and hand stereotypies, behavioral abnormalities are a prevalent and disabling component of the RTT phenotype. Among these problematic behaviors, anxiety is a prominent symptom. While the introduction of the Rett Syndrome Behavioral Questionnaire (RSBQ) represented a major advancement in the field, no systematic characterization of anxious behavior using the RSBQ or other standardized measures has been reported.

methodsThis study examined the profiles of anxious behavior in a sample of 74 girls with RTT, with a focus on identifying the instrument with the best psychometric properties in this population. The parent-rated RSBQ, Anxiety, Depression, and Mood Scale (ADAMS), and Aberrant Behavior Checklist-Community (ABC-C), two instruments previously employed in children with neurodevelopmental disorders, were analyzed in terms of score profiles, relationship with age and clinical severity, reliability, concurrent validity, and functional implications. The latter were determined by regression analyses with the Vineland Adaptive Behavior Scales-Second Edition (Vineland-II) and the Child Health Questionnaire (CHQ), a quality of life measure validated in RTT.

resultsWe found that scores on anxiety subscales were intermediate in range with respect to other behavioral constructs measured by the RSBQ, ADAMS, and ABC-C. Age did not affect scores, and severity of general anxiety was inversely correlated with clinical severity. We demonstrated that the internal consistency of the anxiety-related subscales were among the highest. Test-retest and intra-rater reliability was superior for the ADAMS subscales. Convergent and discriminant validity were measured by inter-scale correlations, which showed the best profile for the social anxiety subscales. Of these, only the ADAMS Social Avoidance showed correlation with quality of life.

conclusionsWe conclude that anxiety-like behavior is a prominent component of RTT's behavioral phenotype, which affects predominantly children with less severe neurologic impairment and has functional consequences. Based on available data on standardized instruments, the ADAMS and in particular its Social Avoidance subscale has the best psychometric properties and functional correlates that make it suitable for clinical and research applications.

Indexed as

AnxietyIntellectual disabilitiesProblematic behaviorRett syndromeSocial avoidance

Identifiers

PMID26379794
PMCPMC4571061
OpenAlexW2105938745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.